Fragmento

I. MOLECULAR AND CELLULAR BIOLOGY 01. CORRELATION OF CHEMOKINES AND METALLOPROTENASES WITH FIBROSIS DEGREE IN CHRONIC HEPATITIS C PATIENTS FLORES-VASCONCELOS I,* ROSIQUE ORAMAS D,* MEDINA ÁVILA Z,* SANTOYO A,* ARELLANO N,* CORDERO P,** MUÑOZ L,** SÁNCHEZ JF,*** KERSHENOBICH D,*** GUTIÉRREZ-REYES G* 02. REFLECTANCE SPECTROSCOPY MAY REPRESENT A COMPLEMENTARY TOOL TO LIVER BIOPSY FOR STAGING FIBROSIS: A PROOF OF CONCEPTCRUZ-AVILÉS E, MANJARRÉZ-REYNA A, MENDOZA-VÁZQUEZ M, GUTIÉRREZ-REYES G, LÓPEZ-VANCELL MD, DURÁN-PADILLA MA, ESCOBEDO G 03. CONNECTIVE TISSUE GROWTH FACTOR PEPTIDE LEVELS DURING LIVER FIBROSIS IN RAT ARÉVALO-SÁNCHEZ TA,* MORENO-GONZÁLEZ J,* RAMÍREZ-MENDOZA A,* ROMERO-BELLO I,* KERSHENOBICH D,** GUTIÉRREZ-REYES G,* GUZMÁN C* 04. HISTOLOGIC CHANGES IN THE LIVER ASSOCIATED TO OBESOGENIC DIET AND CHRONIC ALCOHOL INTAKE IN MICE RAMÍREZ-MENDOZA A,* GALICIA-MORENO M,* AREVALO-SANCHEZ T,* ÁVILA-MEDINA Z,* MORENO-GONZÁLES J,* PÉREZ-GÓMEZ A,* RODRÍGUEZ-ORIHUELA DL,* ROMERO-BELLO II,* ROSIQUE-ORAMAS D,* VEGA-GALAVIZ D,* PÉREZ-TORRES A,** ESCOBEDO G,* GUZMÁN C,* GUTIÉRREZ-REYES G* II. CIRRHOSIS AND ITS COMPLICATIONS 01. ADIPOSITY EXCESS, SKELETAL MUSCLE MASS DEPLETION AND THEIR CORRELATION WITH BODY MASS INDEX IN LIVER CIRRHOSIS GASCA-PONCE M, DOMÍNGUEZ-WAKIDA A, CUEVAS-AGUIRRE A, GÓMEZ-REYES E, LÓPEZ-MÉNDEZ E 02. DECOMPENSATION’S CAUSES REQUIRING HOSPITAL ADMISSION OF PATIENTS WITH CIRRHOSIS HEPATIC, EXPERIENCE IN THE HJM LARGACHA-BARREIRO ML, ZAMARRIPA-DORSEY F, MEJÍA-LOZA SCH, JUÁREZ-BARRIENTOS TE, ESPINOZA-DELGADO DM, HERRERO-MACEDA MR 03. PREDICTING SHORT-TERM MORTALITY IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE USING HYPONATREMIA WITH CLIF-SOFA SCORE MORALES-VILLALOBOS R,* CASTILLO-BARRADAS M** 04. NON-WILSONIAN HEPATOLENTICULAR DEGENERATION AS A SIGN OF HEPATIC CIRRHOSIS TRUJILLO-DE LA FUENTE KC,* RAMÍREZ-POLO A,** LÓPEZ-ESPARZA J,** HERNÁNDEZ-VILLEGAS A, GARCÍA-JUÁREZ I,** SÁNCHEZ-ÁVILA F** 05. DECOMPENSATED LIVER DISEASE; ALERT FOR FINDING MINIMAL HEPATIC ENCEPHALOPATHY (MHE) NUÑEZ-FLORIANO M, RIZO-ROBLES MTG, CASTILLO-BARRADAS M, VARGAS-ÁNGELES R 06. DETERMINATION OF LIVER AND SPLEEN STIFFNESS BY ELASTOGRAPHY (FIBROSCAN) IN PORTAL HYPERTENSION WITHOUT CIRRHOSIS (PORTAL VEIN THROMBOSIS/BUDD-CHIARI SYNDROME) THEIR CORRELATION AND DEPENDENCE WITH ESOPHAGEAL VARICES DOMÍNGUEZ-WAKIDA A, GASCA-PONCE M, GÁLVEZ-CALVO E, MIGUEL-CRUZ A, LÓPEZ-MÉNDEZ E. 07. GASTROINTESTINAL BLEEDING VARICEAL: BE PERFORMED WITH DIAGNOSTIC LABORATORY STUDIES? AVILÉS-GONZÁLEZ A, JUÁREZ-BARRIENTOS T, ÁVILA-LANGARICA M, BARRAGÁN-VALAREZO M, RAMÍREZ-ESCOBAR S, ZAMARRIPA-DORSEY F 08. NATURAL HISTORY OF CIRRHOSIS AND ASSOCIATION WITH NUTRITIONAL STATUS IN MEXICAN POPULATION JUÁREZ-HERNÁNDEZ E, GÓMEZ-GUTIÉRREZ C, BALDERAS-GARCÉS B, ALTAMIRANO-BARRERA A, VALDIVIA-CORREA B, RODRÍGUEZ-GALVÁN A, ALVA-LÓPEZ F, URIBE M, CHÁVEZ-TAPIA NC 09. INDISCRIMINATE USE OF PROTON-PUMP INHIBITORS IN CIRRHOTIC PATIENTS AS RISK FACTOR ASSOCIATED WITH A GREATER FREQUENCY OF BACTERIAL INFECTIONS LÁZARO-PACHECO IB,* SERVÍN-CAAMAÑO AI,** HIGUERA DE LA TIJERA F* 10. PROTEIN-CALORIE MALNUTRITION NEGATIVELY IMPACTS ON THE QUALITY OF LIFE OF PATIENTS WITH CIRRHOSIS ROJAS-LOUREIRO G,* PÉREZ-REYES E,* SERVÍN-CAAMAÑO AI,** HIGUERA-DE LA TIJERA F* 11. ASSOCIATION BETWEEN NUTRITIONAL STATUS AND QUALITY OF LIFE IN PATIENTS WITH CIRRHOSIS JUÁREZ-HERNÁNDEZ E, GÓMEZ-GUTIÉRREZ C, BALDERAS-GARCÉS B, ALVA-LÓPEZ F, URIBE M, CHÁVEZ-TAPIA NC 12. OBESITY AS A FACTOR OF LIVER CIRRHOSIS POOR PROGNOSIS ÁVILA-LANGARICA MA., BARRAGÁN-VALAREZO MA., RAMÍREZ-ESCOBAR S, GONZÁLEZ-ANGULO A, ZAMARRIPA-DORSEY F 13. EFFECT OF THE COMBINATION OF CARVEDILOL AND SIMVASTATIN IN PORTAL PRESSURE GRADIENT IN PATIENTS WITH CIRRHOSIS AFTER VARICEAL BLEEDING (SECONDARY PROPHYLAXIS) DOMÍNGUEZ-WAKIDA A, GASCA-PONCE M, MIGUEL-CRUZ A, SÁNCHEZ-ÁVILA F, CASANOVA-SÁNCHEZ I, MOCTEZUMA-VELÁZQUEZ C, LÓPEZ-MÉNDEZ E 14. COMPARISON BETWEEN LACTULOSE, L-ORNITHINE L-ASPARTATE, OR RIFAXIMIN, VS. PLACEBO, AS PRIMARY PROPHYLAXIS TO AVOID THE DEVELOPMENT OF HEPATIC ENCEPHALOPATHY AFTER VARICEAL BLEEDING IN CIRRHOTIC PATIENTS HIGUERA-DE LA TIJERA F,* SERVÍN-CAAMAÑO AI,** ABDO-FRANCIS JM,* SALAS-GORDILLO F,* PÉREZ-HERNÁNDEZ JL,* CAMACHO-AGUILERA J,** JIMÉNEZ-PONCE F*** 15. LIVER CIRRHOSIS DECOMPENSATION ACCORDING TO ALBI SCORE RAMÍREZ-ESCOBAR SC, ÁVILA-LANGARICA MC, BARRAGÁN-VALAREZO MA, GONZÁLEZ-ANGULO A, ZAMARRIPA-DORSEY F 16. RADIOFREQUENCY ABLATION TREATMENT OF GASTRIC ANTRAL VASCULAR ECTASIA (GAVE) IN PATIENTS WITH LIVER CIRRHOSIS. REPORT OF TWO CASES MIRELES-ÁLVAREZ CA,* BETANCOURT-SÁNCHEZ F,* HERNÁNDEZ-JAIME M,* MEDINA-MEDRANO MA,* LANGLE CASTRO H,* MALÉ-VELÁZQUEZ R* 17. NON-SELECTIVE BETABLOCKERS AS AN INDEPENDENT RISK FACTOR FOR DEVELOPMENT OF SPONTANEOUS BACTERIAL PERITONITIS WITH DECOMPENSATED LIVER CIRRHOSIS AMADOR GARCÍA R, BARRADAS CASTILLO M. 18. STREPTOCOCCUS SALIVARIUS AS CAUSE OF SPONTANEOUS BACTERIAL PERITONITIS. CASE REPORT RIVERA FLORES AG, MEJÍA S, GARCÍA E, ZAMARRIPA F III. AUTOIMMUNE AND CHRONIC CHOLESTATIC DISEASES 01. BONE DISEASE IN PRIMARY BILIARY DISEASE HERRERO-MACEDA MR, ERAZO-TAPIA E, JUÁREZ-BARRIENTOS TE, ESPINOZA DELGADO DM, LARGACHA-BARREIRO ML, AVILÉS-GONZÁLEZ AG, MEJÍA-LOZA SMI 02. HGF INDUCES A PROTECTIVE EFFECT IN A MOUSE MODEL OF CHOLESTASIS SALAS-SILVA S,* SIMONI-NIEVES A,* BELLO-MONROY O,* GÓMEZ-QUIROZ LE,* MÉNDEZ-SÁNCHEZ N,** ROMA M,*** GUTIÉRREZ-RUIZ MC* IV. VIRAL HEPATITIS 01. ANALYSIS OF DIFFERENTIAL PROTEOMIC PROFILES EXPRESSION WITH GALLIC ACID IN HUH7 CELLS INFECTED WITH HEPATITIS C VIRUS GOVEA-SALAS M,* RIVAS-ESTILLA AM,** LOZANO-SEPÚLVEDA SA,** SALAS-VILLALOBOS TB,** AGUILAR-GONZÁLEZ CN,* RODRÍGUEZ-HERRERA R,* BELMARES-CERDA RE,* MORLETT-CHÁVEZ JA* 02. S-ADENOSYLMETHIONINE (SAM) DECREASES HEPATITIS C VIRUS (HCV) REPLICATION BY MODULATING UBIQUITINATION AND PROTEASOME ACTIVITY LOZANO-SEPÚLVEDA SA,* LOPITZ-OTSOA F,** VARELA-REY M,** MARTÍNEZ-CHANTAR ML,** MATO JM,** RIVAS-ESTILLA AM* * 03. NEGATIVE REGULATION OF HEPATITIS C VIRUS BY HEPATOCYTE GROWTH FACTOR IN HUH-7 CELLS BAUTISTA-OSORIO E, LOZANO-SEPÚLVEDA S, MERINO-MASCORRO JA, SALAS-VILLALOBOS T, RIVAS-ESTILLA AM 04. UANTIFICATION OF CONNECTIVE TISSUE GROWTH FACTOR DURING RAT LIVER FIBROSIS REVERSION ARÉVALO-SÁNCHEZ TA,* MORENO-GONZÁLEZ J,* RAMÍREZ-MENDOZA A,* ROMERO-BELLO I,* KERSHENOBICH D,** GUTIÉRREZ-REYES G,* GUZMÁN C* 05. CHRONIC HEPATITIS C TREATMENT WITH DIRECT ANTIVIRAL AGENTS IN A REAL LIFE SETTING CHIRINO-SPRUNG RA,* DEHESA-VIOLANTE M,† WOLPERT-BARRAZA E,‡ CORONA-LAU C,§ GARCÍA-JUAREZ I,|| SÁNCHEZ-ÁVILA F,|| MOCTEZUMA-VELÁZQUEZ C,|| KERSHENOBICH-STALNIKOWITZ D|| 06. EXPERIENCE A YEAR OF TREATMENT IN PATIENTS WITH CHRONIC INFECTION FOR HEPATITIS C VIRUS IN HOSPITAL GENERAL DE MÉXICO CÓRDOBA-REYES JM, HIGUERA-DE LA TIJERA F, SARABIA-ALDANA C, PÉREZ-HERNÁNDEZ JL 07. HIGH EFFICACY (SVR) IN REAL LIFE OF DDA INTERFERON FREE ANTIVIRAL REGIMEN IN MEXICAN PATIENTS WITH CHRONIC HEPATITIS C MALÉ-VELÁZQUEZ R, MIRELES-ÁLVAREZ CA, HERNÁNDEZ-JAIME M, MEDINA-MEDRANO MA, COLUNGA-LOZANO LE, DE LA TORRE GONZÁLEZ P, LANGLE CASTRO H, BETANCOURT-SÁNCHEZ F 08. IS THERE LIVER FIBROSIS REGRESSION AFTER INTERFERON FREE ANTIVIRAL REGIMEN TREATMENT FOR HEPATITIS C VIRUS? RESULTS TRANSIENT ELASTOGRAPHY PRE AND POSTTREATMENT BETANCOURT-SÁNCHEZ F,* MIRELES-ÁLVAREZ CA,* HERNÁNDEZ-JAIME M,* MEDINA-MEDRANO MA,* DE LA TORRE GONZÁLEZ P,* LANGLE CASTRO H,* COLUNGA-LOZANO LE,* MALÉ-VELÁZQUEZ R* 09. HEPATITIS E VIRUS IN PATIENTS WITH HCV OR HBV. CROSS-SECTIONAL STUDY MÉNDEZ-SÁNCHEZ N,* TRUEBA GÓMEZ R,** ROSENFELD MANN F,** NOFFAL NUÑO V,*** ROQUE ÁLVAREZ E,** URIBE M,* BAPTISTA-GONZÁLEZ H** V. PEDIATRIC HEPATOLOGY 01. CLINICAL FEATURES IN CHILDREN WITH AUTOINMUNE HEPATITIS OGAZ-CAMPOS AC, FLORES-CALDERÓN J, LEDESMA-RAMÍREZ S, GONZÁLEZ-ORTIZ B 02. EXPERIENCE OF MOLECULAR ADSORBENT RECIRCULATING SYSTEM IN FULMINANT HEPATIC FAILURE IN CHILDRENS ARTEAGA-Y-HERNÁNDEZ-MAGRO M, MIRANDA-BARBACHANO K, MONROY-TENIZA Z, MOLINA-PETO A, AGRAZ-ORTIZ D, FLORES-CALDERÓN J VI. ALCOHOLIC LIVER DISEASE - FATTY LIVER 01. EVALUATION OF CYTOKINES LEVELS IN SUBJECTS WITH DIFFERENT PATTERN OF ALCOHOL CONSUMPTION MEDINA-ÁVILA Z,* ROSIQUE ORAMAS D,* GALICIA MORENO M,* BÉJAR Y,** HIGUERA F,** PÉREZ-HERNÁNDEZ JL,** KERSHENOBICH D,* GUTIÉRREZ-REYES G* 02. TLR-4 EXPRESSION IN MONOCYTES PERIPHERAL BLOOD OF ALCOHOLICS AND ALCOHOLIC CIRRHOTIC PATIENTS ROSIQUE ORAMAS D,* MEDINA ÁVILA Z,* GALICIA MORENO M,* ARELLANO N,* SANTOYO A,* HERNÁNDEZ-RUIZ J,* PÉREZ HERNÁNDEZ JL,** HIGUERA DE LA TIJERA F,** KERSHENOBICH D,* GUTIÉRREZ-REYES G* 03. PROGNOSTIC MODELS IN PATIENTS WITH ALCOHOLIC HEPATITIS ENRÍQUEZ-COVARRUBIAS P,* SERVÍN-CAAMAÑO AI,** CÓRDOBA REYES JM,* PÉREZ-HERNÁNDEZ JL,* HIGUERA-DE LA TIJERA F* 04. MAIN CAUSES OF HOSPITAL RE-ENTRY FOR ALCOHOL LIVER PATIENTS IN JALISCO CASAL-SÁNCHEZ J,* VELARDE RUIZ-VELASCO JA,* ÁLVAREZ-LÓPEZ F,* MUÑOZ-CORTÉS J,* PINEDO-GÓMEZ J,** BERGENS A,*** SUDER-CASTRO LS,* OLIVARES-GUZMÁN LO,* CERVANTES GUEVARA G,* SEGURA ORTEGA JE* 05. HISTOLOGIC CHANGES IN THE LIVER ASSOCIATED TO OBESOGENIC DIET AND CHRONIC ALCOHOL INTAKE IN MICE RAMÍREZ-MENDOZA A,* GALICIA-MORENO M,* ARÉVALO-SÁNCHEZ T,* ÁVILA-MEDINA Z,* MORENO-GONZÁLES J,* PÉREZ-GÓMEZ A,* RODRÍGUEZ-ORIHUELA DL,* ROMERO-BELLO II,* ROSIQUE-ORAMAS DOROTHY,* VEGA-GALAVIZ D,* PÉREZ-TORRES A,**ESCOBEDO G,* GUZMÁN C,* GUTIÉRREZ-REYES G* 06. HEPATIC STEATOSIS PRODUCED BY DOUBLE INSULT (DIET AND ALCOHOL): EXPERIMENTAL MODEL LEÓN MANCILLA B, GALICIA-MORENO M, ROSIQUE-ORAMAS D, MEDINA-ÁVILA Z, VELASCO K, ARÉVALO-SÁNCHEZ T, RAMÍREZ-MENDOZA A, MORENO-GONZÁLES J, ROMERO-BELLO I, HERNÁNDEZ J, ESCOBEDO G, GUZMÁN C, GUTIÉRREZ-REYES G 07. UTILITY OF NON-INVASIVE METHODS TO DIAGNOSE ADVANCED FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE. A RANDOMIZED CLINICAL CONTROLLED TRIAL OF 1,213 PATIENTS SÁNCHEZ-JIMÉNEZ BA,* LÓPEZ-GIL S,* JUÁREZ-HERNÁNDEZ E,* RAMOS-OSTOS MH,** PÉREZ-JAUREGUÍ J,*** URIBE M,* CHÁVEZ-TAPIA NC* 08. PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE AND INSULIN RESISTANCE IN PEDIATRIC PATIENTS WITH OVERWEIGHT AND OBESITY VERDEJA-PADILLA PA,* MEJÍA L,** MEDINA-ÁVILA Z,* ARELLANO N,* CRUZ-BAUTISTA R,** SUÁREZ L,** ROSIQUE-ORAMAS D,* GALICIA-MORENO M,* CORDERO P,*** MUÑOZ L,*** GUTIÉRREZ-REYES G* 09. SYSTEMIC LEVELS OF IL-4 DECREASE ACCORDING TO THE SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OBESE PATIENTS MENDOZA-VÁZQUEZ M, CRUZ-AVILÉS E, MANJARREZ-REYNA A, GUTIÉRREZ-REYES G, ESCOBEDO G 10. SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE ASSOCIATES WITH HIGH SERUM LEVELS OF INTERLEUKIN 1 BETA IN OBESE PATIENTS MANJARREZ-REYNA A, CRUZ-AVILÉS E, MENDOZA-VÁZQUEZ M, GUTIÉRREZ-REYES G, ESCOBEDO G* 11. RELATIONSHIP BETWEEN TIME OF DIAGNOSIS AND PRESENCE OF LIVER DAMAGE IN DIABETES MELLITUS 2 PATIENTS FROM DIABETIMSS CLINIC, HGZMF NO. 1 CONTRERAS-OMAÑA R.,* URIBE-TORRES Y,* TÉLLEZ-JAÉN S** 12. CORRELATION BETWEEN THE DYSGLYCEMIC STATE AND THE RISK OF SIGNIFICANT LIVER FIBROSIS SARABIA-ALDANA CA,* CALLE-RODAS DA,** SERVÍN-CAAMAÑO AI,**,*** VANEGAS-HERRERA JA,*** CRUZ-ESTRADA A,* CAMACHO-AGUILERA J,**** CÓRDOBA-REYES JM,* HIGUERA-DE LA TIJERA F* 13. SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE AND METABOLIC RISK PHENOTYPE IN OBESE PATIENTS SUÁREZ-CUENCA JA,* MELCHOR-LÓPEZ A,* ORTIZ-FERNÁNDEZ M,** DE-LA-ROSA GA,* VEGA-ROJAS NB,* GERMÁN-BARRAZA AE* 14. ASSOCIATION OF HEMOGLOBIN SERUM LEVELS IN NON ALCOHOLIC FATTY LIVER DISEASE NUÑO-LÁMBARRI N, JUÁREZ-HERNÁNDEZ E, SÁNCHEZ-JIMÉNEZ B, LÓPEZ-GIL S, BARBERO-BECERRA V, URIBE-RAMOS MH, RAMOS-OSTOS MH, URIBE M, CHÁVEZ-TAPIA NC 15. CORRELATION BETWEEN BODY MASS INDEX AND LIVER DAMAGE IN CHILDREN POPULATION WITH OBESITY AT THE HGZMF NO. 1 IMSS HIDALGO CONTRERAS-OMAÑA R,* MUÑOZ-PINEDA MA,** TÉLLEZ-JAÉN S*** 16. PEDIATRIC VISCERAL ADIPOSITY INDEX ADAPTATION CORRELATES WITH HOMA-IR, MATSUDA AND TRANSAMINASES GARCÉS MJ,* KLÜNDER-KLÜNDER M,** GARIBAY-NIETO N,* LÓPEZ-ALVARENGA JC,*** QUISPE-SICCHA R,* KERSHENOBICH D,**** HERNÁNDEZ-RUIZ J* 17. IMPROVEMENT OF THE METABOLIC PROFILE AND LIVER FUNCTION TESTS IN OBESE PATIENTS AFTER BARIATRIC SURGERY HIGUERA-DE LA TIJERA F,* CALLE-RODAS DA,** VANEGAS-HERRERA JA,*** CRUZ-ESTRADA A,** CAMACHO-AGUILERA J,**** SERVÍN-CAAMAÑO AI**,*** VII. OTHER TOPICS 01. ANALYSIS OF THE SCATTERING IN THE DEGREE OF LIVER FIBROSIS IN A CCl4 INDUCED MURINE MODEL PÉREZ-GARCÍA A*, SÁNCHEZ-MELECIO J*, SILVA-AGUILERA FS*, ALEMÁN-GARCÍA N**, GARCÍA-CADENA C.**, DURÁN-PADILLA M***, GUTIÉRREZ-HERRERA E***,KERSHENOBICH D****, SÁNCHEZ-PÉREZ C**, HERNÁNDEZ-RUIZ J.*,***** 02. IT IS POSSIBLE TO APPLY BAVENO VI TO SUSPECTED COMPENSATED CIRRHOSIS ON MEXICAN POPULATION? BARRAGÁN VALAREZO MA., ÁVILA LANGARICA MA., RAMÍREZ ESCOBAR S, GONZÁLEZ ANGULO A, ZAMARRIPA DORSEY F 03. LIVER FUNCTION TESTS AND CHIKUNGUNYA VIRUS INFECTION IN PATIENTS FROM THE RECENT OUTBREAK IN MEXICO, 2015 SALAS-VILLALOBOS TB,* GALÁN-HUERTA KA,* RIVAS-ESTILLA AM,* SOSA-CABALLERO S,** FERNÁNDEZ-SALAS I,*** RAMOS-JIMÉNEZ J* 04. COLONIC VARICES AS A COMPLICATION OF PRE-HEPATIC PORTAL HYPERTENSION DUE TO ACUTE PANCREATITIS AND PORTO-SPLENO THROMBOSIS RÁBAGO-ESCOTO R,* GÁLVEZ-MARTÍNEZ M,* HIGUERA-DE LA TIJERA F* 05. ANTHROPOMETRIC, BIOCHEMICAL, CLINICAL AND DIETETIC INDICATORS RELATED TO THE RISK OF MALNUTRITION IN HOSPITALIZED PATIENTS WITH LIVER CIRRHOSIS. TWEAKING SCREENING TOOLS DÁVILA-BONILLA S, GUTIÉRREZ-MARTÍNEZ G, ROMÁN-CUEVAS LM, MARTÍNEZ-VÁZQUEZ SE 06. ANTHROPOMETRIC AND BIOCHEMICAL CHARACTERISTICS OF PATIENTS WITH LIVER CIRRHOSIS BY HEPATITIS C VIRUS (HCV) ACCORDING TO GENOTYPE. AN EXPLORATORY STUDY RODRÍGUEZ-VÁZQUEZ IC, MOCTEZUMA-VELÁZQUEZ C, GUTIÉRREZ-ZAMORA NAVARRO M, DE LA ROSA-DIEZ SG, MARTÍNEZ-VÁZQUEZ S 07. DETECTION OF WINDOW PERIOD HEPATITIS C AND OCCULT HEPATITIS B INFECTIONS IN BLOOD DONORS FROM VERACRUZ LÓPEZ-BALDERAS N,* BRAVO-SARMIENTO E,** HERNÁNDEZ-ROMANO P** 08. EPIDEMIOLOGY OF INFECTION BY HEPATITIS C VIRUS IN THE GASTROENTEROLOGY SERVICE, ISSSTE TLAXCALA PEÑA-DÁZ P*, PILIADO-PAEZ H*, AGUILAR- RAMÍREZ JR** 09. IDIOPATHIC NON CIRRHOTIC PORTAL HYPERTENSION. A CASE REPORT RODRÍGUEZ PÉREZ PA, ARCE AYALA JA, MARTÍNEZ LÓPEZ H, ORDAZ GARCÍA A, GARRIDO SÁNCHEZ GA, PÉREZ RODRÍGUEZ JA, REBOLLO HURTADO V, AGUILAR RAMÍREZ JR, CERDA REYES E 10. PREVALENCE OF POLYMORPHISM RS738,904 PNPLA-3 [I148M] IN MEXICAN POPULATION AND ITS RELATIONSHIP WITH BODY MASS INDEX (BMI) MEDINA-MARTÍNEZ D,* VELÁZQUEZ-GONZÁLEZ A,** GARCÍA-JUÁREZ I,* CASTRO-NARRO GE,* SÁNCHEZ-ÁVILA JF,* SIXTOS-ALONSO MS* 11. PRETREATMENT SCORING MODEL (PRET-SM) AS A PREDICTOR OF SUSTAINED VIROLOGICAL RESPONSE (SVR) IN PATIENTS WITH CHRONIC INFECTION OF HEPATITIS C VIRUS (HCV) GENOTYPE 1 GARCÍA-GARCÍA F, CASTILLO BARRADAS M 12. FREQUENCY OF DIETARY SODIUM RESTRICTION IN AMBULATORY CIRRHOTIC PATIENTS LÓPEZ-SÁNCHEZ M,* TAPIA-SOTO Y,* CORTEZ-ZURITA C,* RIVERA-FLORES R,* MINA-HAWAT A,* ORTIZ-OLVERA N,** MORENO-ALCÁNTARA R,** MORÁN-VILLOTA S* 13. SCREENING TOOLS AND ITS CORRELATION WITH OBJETIVE ASSESSMENT OF NUTRITIONAL STATUS IN PATIENTS WITH LIVER CIRRHOSIS ROMÁN-CUEVAS LM, GUTIÉRREZ-MARTÍNEZ G, DÁVILA-BONILLA S, MARTÍNEZ-VÁZQUEZ SE VIII. TRANSPLANT 01. HCV GENOTYPES AROUND THE ORTHOTOPIC LIVER TRANSPLANTATION AND POLYMORPHISM Q80K JOANICO-AGUILAR R, LÓPEZ-MÉNDEZ YI, LEÓN-PÉREZ S, GARCÍA-GARCÍA C, SIXTOS-ALONSO S, PINEDA-DE-PAZ MR, LEAL-VILLALPANDO PR, CONTRERAS-SALDÍVAR AG, VILATOBÁ-CHAPA M, CASTRO-NARRO GE 02. PREVALENCE OF HEPATOPULMONARY SYNDROME AND HEPATOPULMONARY IN PATIENTS VALUED FOR LIVER TRANSPLANT, GRAVITY AND ITS CLINICAL SIGNIFICANCE JOANICO-AGUILAR R, LÓPEZ-MÉNDEZ YI, GASCA-PONCE MC, LEÓN-PÉREZ S, GARCÍA-GARCÍA C, SIXTOS-ALONSO S, PINEDA-DE-PAZ MR, LEAL-VILLALPANDO PR, CONTRERAS-SALDÍVAR AG, VILATOBÁ-CHAPA M, CASTRO-NARRO GE 03. LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS SENT TO VALUATION OF LIVER TRANSPLANT, A STUDY OF CASE AND CONTROLS JOANICO-AGUILAR R, LÓPEZ-MÉNDEZ YI, LEÓN-PÉREZ S, GARCÍA-GARCÍA C, SIXTOS-ALONSO S, PINEDA-DE-PAZ MR, CASTRO-NARRO GE 04. FIBROSIS REGRESSION AFTER TREATMENT WITH TRIPLE THERAPY IN PATIENTS WITH LIVER TRANSPLANT FOR HEPATITIS C VIRUS JOANICO-AGUILAR R,* LÓPEZ-MÉNDEZ YI,* GÓNZALEZ-HUEZO S,** LEÓN-PÉREZ S,* GARCÍA-GARCÍA C,* SIXTOS-ALONSO S,* PINEDA-DE-PAZ MR,* LEAL-VILLALPANDO PR,* CONTRERAS-SALDÍVAR AG,* VILATOBÁ-CHAPA M,* CASTRO-NARRO GE* 05. STEATOSIS AND FIBROSIS IN POST-LIVER TRANSPLANT PATIENTS AND ITS RELATION TO NUTRITIONAL STATUS GUTIÉRREZ-ZAMORA-NAVARRO M, RODRÍGUEZ-VÁSQUEZ IC, DE LA ROSA-DIEZ-SG, TORRES-VANEGAS J, JOANICO R, CHÁVEZ J, CASTRO-NARRO GE, MARTÍNEZ-VÁZQUEZ SE 06. IMPACT ON THE QUALITY OF LIFE IN PATIENTS IN WAITING LIST FOR ORTHOTOPIC LIVER TRANSPLANTATION (OLT) AFTER A NUTRITIONAL INTERVENTION CHÁVEZ-VELÁZQUEZ JH, SIXTOS-ALONSO M, LÓPEZ-MÉNDEZ YI, GÓMEZ-REYES E, TORRES-VANEGAS J, LEÓN-PÉREZ S, PINEDA-DE PAZ M, JOANICO-AGUILAR R, VILATOBÁ-CHAPA M, LEAL-VILLALPANDO PR, CONTRERAS-SALDÍVAR A, CASTRO-NARRO GE 07. IMPLICATION OF OBESITY IN THE EVOLUTION POST ORTHOTOPIC LIVER TRANSPLANTATION AT 24 MONTHS COMPARED WITH A CONTROL GROUP LEÓN-PÉREZ S, PINEDA-DE PAZ M, LÓPEZ-MÉNDEZ YI, GÓMEZ-REYES E, SIXTOS-ALONSO M, CHÁVEZ-VELÁZQUEZ J, JOANICO-AGUILAR R, TORRES-VANEGAS J, LEAL-VILLALPANDO PR, CONTRERAS-SALDÍVAR A, VILATOBÁ-CHAPA M, CASTRO-NARRO GE 08. SARCOPENIA IN OBESE PATIENTS WITH CIRRHOSIS EVALUATION FOR LIVER TRANSPLANTATION PINEDA-DE PAZ M, LÓPEZ-MÉNDEZ YI, CHÁVEZ-VELÁZQUEZ J, TORRES-VANEGAS J, LEÓN-PÉREZ S, JOANICO-AGUILAR R, SIXTOS-ALONSO M, CASTRO-NARRO GE 09. INFLAMMATORY INDICATORS DECREASE WITH BRANCHED CHAIN AMINO ACID SUPPLEMENTATION IN PATIENTS WITH CIRRHOSIS SENT TO LIVER TRANSPLANT EVALUATION 10. RETROGRADE CHOLANGIOGRAPHY ENDOSCOPY WITH SINGLE BALLOON ASSISTED ENTEROSCOPY (RCE-SBAE) FOR TREATMENT OF ANASTOMOTIC BILIODIGESTIVE STRICTURE IN LIVER TRANSPLANT. REPORT OF 3 CASES BETANCOURT-SÁNCHEZ F, MIRELES-ÁLVAREZ CA, HERNÁNDEZ-JAIME M, MEDINA-MEDRANO MA, RODRÍGUEZ SANCHO LC, MALÉ-VELÁZQUEZ R 11. EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF PATIENTS REFERRED FOR EVALUATION FOR LIVER TRANSPLANTATION IN TRASPLANT UNIT OF HOSPITAL GENERAL CENTRO MÉDICO NACIONAL LA RAZA, IMSS MARTÍNEZ SALDÍVAR B,* HERNÁNDEZ DOMÍNGUEZ M,** SANTOS CABALLERO M,*** FLORES-ARROYO,**** DÍAZ PINEDA M,***** SANSÓN NAVARRO G***** 12. WALK TEST SIX MINUTES PREDICTOR OF PERIOPERATIVE COMPLICATIONS IN PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION ROSAS-FLORES AP, LEAL-VILLALPANDO RP, VILATOBÁ-CHAPA M, CONTRERAS-SALDÍVAR A, CASTRO-NARRO GE, GARCÍA I, ZAMUDIO-BAUTISTA JL IX. LIVER TUMORS 01. HEPATIC EPITHELIOID HEMANGIOENDOTHELIOMA: A CASE REPORT FLOREZ-MEDELLIN D,* GALINDO-OROZCO M,* GARCÍA-AGUILAR B,** CASTILLO-BARRADAS M* 02. HEPATOCELLULAR CARCINOMA AS SECOND LEADING MORTALITY CAUSE BY MALIGNANT NEOPLASM IN HIDALGO, MEXICO: SURVEILLANCE FROM THE MINISTRY OF HEALTH 1990-2013 CONTRERAS OMAÑA R,* BARRERA CORTÉS RI** 03. IMPACT OF NASH IN THE ETIOLOGY OF HCC IN THE NORTHEAST OF MEXICO MUÑOZ LE, APARICIO JE, ZAPATA HA, CORDERO P, ELIZONDO G, ALARCÓN G, PÉREZ E, ESCOBEDO MM 04. SIMPLE LIVER CYST AND POLYCYSTIC DISEASE INCIDENCE IN THE HOSPITAL JUÁREZ DE MÉXICO ESPINOZA-DELGADO D, MEJÍA-LOZA S, JUÁREZ-BARRIENTOS T, HERRERO-MACEDA M, LARGACHA-BARREIRO M, AVILÉS-GONZÁLEZ A, ZAMARRIPA-DORSEY F 05. MANAGEMENT OF HEPATOCELLULAR CARCINOMA WITH CELECOXIB AND PENTOXIFYLLINE: CASE REPORT JIMÉNEZ-LUÉVANO MA, RODRÍGUEZ-CHÁVEZ JL, RAMÍREZ-FLORES S, RODRÍGUEZ-VILLA P, JIMÉNEZ-PARTIDA MA, CERVANTES-RODRÍGUEZ G, FRANCO-TOPETE R, BRAVO-CUELLAR A 06. LIVER CANCER IN ELDERLY MEXICAN WOMEN IS MORE FREQUENT THAN BREAST AND CERVICAL CANCER VILLA AR,* HERNÁNDEZ T,* PÉREZ JM,* MEJÍA C,* URIBE M,** PATEL TC,*** MÉNDEZ-SÁNCHEZ N**

Palabras clave:

2016-06-23   |   1,017 visitas   |   Evalua este artículo 0 valoraciones

Vol. 15 Núm.4. Julio-Agosto 2016 Pags. 611-618 Ann Hepatol 2016; 15(4)